WinstonWınston
Back
LIMES Schlosskliniken AG logo

LIMES Schlosskliniken AG

LIK.DE
69
Medical - Care Facilities · Healthcare
Price
€575.00
+5.00 (+0.88%)
Market Cap
€171.3M
Exchange
Frankfurt Stock Exchange
Winston Score
69
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Dec 31, 2025
How the score breaks down
Quality
Good
Growth
Strong
Cash Flow
Strong
Stability
Exceptional
Valuation
Strong
Dividends
Weak

Share count rising — dilution

+1.6% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 293K (2021) → 298K (2025)

Winston Score History

The full picture

LIMES Schlosskliniken AG is a German private healthcare company that runs a small network of upscale rehabilitation and mental health clinics. Its facilities focus on treating burnout, depression, addiction, and stress-related conditions, primarily serving affluent private-pay patients and those with premium private health insurance. The clinics are positioned in the luxury segment of the German inpatient psychiatric and psychosomatic care market.

The company earns revenue by charging daily rates for inpatient stays, with most income coming directly from private insurers or out-of-pocket payments rather than the public statutory health system. It operates exclusively in Germany and remains a very small company with a market cap around €100 million. Its moat comes from its premium brand, limited bed capacity, and high barriers to replicating the castle-like clinic settings it is known for. The key risk is its narrow geographic and demographic focus — growth depends heavily on expanding bed capacity or opening new sites, while any tightening of private insurance reimbursement rates could pressure margins.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+43.1% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+82.4% YoY

YoY Growth Rate

Strong earnings growth

R&D Spend

€0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

75.0%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

€10M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Company generates more cash than it spends — no dilution risk from fundraising

Revenue accelerating

LIMES Schlosskliniken AG grew revenue 43% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
35.4%
Modest — 35.4% gross margin
Profit after running costs
Operating Margin
16.3%
Healthy — 16.3% operating margin
Return on the money invested
ROCE
25.8%
Exceptional — 25.8% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+33.5%
Fast-growing sales (+33.5% YoY)
Profit growth
EPS YoY
+81.6%
Earnings growing fast (+81.6% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
165%
Turns 165% of profit into real cash
Spare cash per sale
FCF Margin
1.5%
Thin free cash flow (1.5%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.42
Conservative — low debt load (0.42)
Covers its interest
Interest Cover
39.72x
Comfortably covers interest (39.7x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
29.8x
Growth-priced — P/E 29.8

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
+13.7
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (29.8 → 16.2)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
1.74%
Small dividend — 1.74% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial